+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-03-22Number of Pages: 165

Tumor Ablation Market (Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation; Disease Indication - Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, and Prostate Cancer; End Users - Hospitals and Cancer Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024

Global Tumor Ablation Market: Snapshot

The tumor ablation market is showcasing an enormous potential for growth across the world. The alarming increase in the incidence of cancer and, particularly, the rising prevalence of tumor in humans. The continual advancements in ablation technology, leading to the increased development of new and innovative products that are the safe, efficient, and have minimal side effects., are also boosting the growth of the global market for tumor ablation significantly.

Going forward, the growing cases of bile duct cancer and primary liver cancer are anticipated to drive this market substantially over the forthcoming years. Along with this, the rise in the geriatric population base and the escalating consumption of alcohol and smoking are also projected to propel this market in the near future. The worldwide market for tumor ablation offered an opportunity worth US$702.9 mn in 2015, which is likely to increase to US$1.9 bn by 2024, expanding at a CAGR of 12.20% over the period from 2016 to 2024.

tumor ablation market

 

Increasing Popularity of Radiofrequency Ablation to Ensure its Dominance

Based on technology, the global market for tumor ablation has been categorized into radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, and laser interstitial thermal ablation. Among these, the radiofrequency ablation technology segment has been leading the global market in terms of revenue. Expanding at a CAGR of 10.90% between 2016 and 2024, the segment is likely to maintain its lead in this market in the near future.

The growing awareness about the benefits of tumor ablation through radiofrequency, such as its efficiency, less risk of tissue damage, and faster recovery, is likely to fuel its demand substantially over the next few years. The fact that the patient requires going through only one treatment session for tumor destruction when radiofrequency ablation technology is used, is adding significantly to its popularity, which is also anticipated to push its adoption rate upwards in the years to come. Apart from this, the uptake of microwave technology for tumor ablation is also increasing considerably, which is expected to reflect positively on the market share of this segment over the forthcoming years.

Technological Advancements to Propel North America Tumor Ablation Market

Geographically, the worldwide market for tumor ablation has been classified into Asia Pacific, the Middle East and Africa, North America, Latin America, and Europe. In 2015, North America dominated the overall market with a share of 30% due to the early adoption of the treatment procedure. The regional market is likely to remain on the top over the forthcoming years, thanks to the technological advancements, rising base of geriatric population, and the high prevalence of cancer.

Europe stood second in the global tumor ablation market in 2015. Driven by the increasing tobacco and alcohol consumption, rise in research activity, presence of a large base of the geriatric population, and the growing awareness among consumers, the Europe market for tumor ablation is anticipated to retain its position in the years to come.

Among other regional markets for tumor ablation, Asia Pacific is predicted to present the most promising growth opportunities in the near future on the ground of soaring unmet medical needs, rising medical expenditures in emerging economies, rapidly expanding capital in research and development in medical and healthcare, and the increasing focus of global players on this region.

EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp., BTG International Ltd., Integra LifeSciences Holdings Corp., and Medtronic plc. are some of the key enterprises functional in the global tumor ablation market.

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Tumor Ablation Products Market Overview
     4.1 Introduction (Product Definition)
     4.2 Industry Evolution/Development 
     4.3 Key Market Indicators
     4.4 Market Dynamics
           4.4.1 Drivers
           4.4.2 Restraints
           4.4.3 Opportunity
     4.5 Global Tumor Ablation Market Analysis and Forecasts, 2014 – 2024
     4.6 Tumor Ablation Market - Global Supply Demand Scenario
     4.7 Porter’s Five Force Analysis
     4.8 Value Chain Analysis
     4.9 Market Outlook

5. Global Tumor Ablation Market Analysis and Forecast by Technology
     5.1 Key Findings
     5.2 Introduction
     5.3 Market Size (US$ Mn) Forecast, By Technology
           5.3.1 Radiofrequency Ablation
           5.3.2 Microwave Ablation
           5.3.3 Cryoablation
           5.3.4 High-Intensity Focused Ultrasound
           5.3.5 Laser Interstitial Thermal Ablation
           5.3.6 Others
     5.4 Market Attractiveness, By Technology
     5.5 Key Trends

6. Global Tumor Ablation Market Analysis and Forecast by Disease Indication
     6.1 Key Findings
     6.2 Introduction
     6.3 Market Size (US$ Mn) Forecast, By Disease Indication
           6.3.1 Liver cancer
           6.3.2 Lung cancer
           6.3.3 Kidney cancer
           6.3.4 Bone cancer
           6.3.5 Breast cancer
           6.3.6 Prostate cancer
           6.3.7 Others
     6.4 Market Attractiveness, By Disease Indication
     6.5 Key Trends

7. Global Tumor Ablation Market Analysis and Forecast by End User
     7.1 Key Findings
     7.2 Introduction
     7.3 Market Size (US$ Mn) Forecast, By End User
           7.3.1 Home Users
           7.3.2 Clinics
           7.3.3 Hospitals
     7.4 Market Attractiveness, By End User
     7.5 Key Trends

8. Global Tumor Ablation Market Analysis and Forecast by Region
     8.1 Key Findings
     8.2 Introduction
           8.2.1 Market Size (US$ Mn) Forecast, By Region
           8.2.2 North America
           8.2.3 Europe
           8.2.4 Asia Pacific
           8.2.5 Latin America
           8.2.6 Middle East and Africa

9. North America Tumor Ablation Market Analysis and Forecast by Region
     9.1 Key Findings
     9.2 North America Tumor Ablation Market Forecast, by Technology
     9.3 North America Tumor Ablation Market Forecast, by Disease Indication
     9.4 North America Tumor Ablation Market Forecast, by End User
     9.5 North America Tumor Ablation Market Forecast, by Country
           9.5.1 U.S. Tumor Ablation Market Overview
           9.5.2 Canada Tumor Ablation Market Overview
     9.6 North America Market Attractiveness Analysis
     9.7 Market Trends

10. Europe Tumor Ablation Market Analysis and Forecast by Region
     10.1 Key Findings
     10.2 Europe Tumor Ablation Market Forecast, by Technology
     10.3 Europe Tumor Ablation Market Forecast, by Disease Indication
     10.4 Europe Tumor Ablation Market Forecast, by End User
     10.5 Europe Tumor Ablation Market Forecast, by Country
           10.5.1 U.K. Tumor Ablation Market Overview
           10.5.2 Germany Tumor Ablation Market Overview
           10.5.3 France Tumor Ablation Market Overview
           10.5.4 Italy Tumor Ablation Market Overview
           10.5.5 Spain Tumor Ablation Market Overview
           10.5.6 Russia Tumor Ablation Market Overview
           10.5.7 Rest of Europe Tumor Ablation Market Overview
     10.6 Europe Market Attractiveness Analysis
     10.7 Market Trends

11. Asia Pacific Tumor Ablation Market Analysis and Forecast by Region
     11.1 Key Findings
     11.2 Asia Pacific Tumor Ablation Market Forecast, by Technology
     11.3 Asia Pacific Tumor Ablation Market Forecast, by Disease Indication
     11.4 Asia Pacific Tumor Ablation Market Forecast, by End User
     11.5 Asia Pacific Tumor Ablation Market Forecast, by Country
           11.5.1 India Tumor Ablation Market Overview
           11.5.2 China Tumor Ablation Market Overview
           11.5.3 Japan Tumor Ablation Market Overview
           11.5.4 Australia of Asia Pacific Tumor Ablation Market Overview
           11.5.5 Rest of APAC Tumor Ablation Market Overview
     11.6 Asia Pacific Market Attractiveness Analysis
     11.7 Market Trends

12 Latin America Tumor Ablation Market Analysis and Forecast by Region
     12.1 Key Findings
     12.2 Latin America Tumor Ablation Market Forecast, by Technology
     12.3 Latin America Tumor Ablation Market Forecast, by Disease Indication
     12.4 Latin America Tumor Ablation Market Forecast, by End User
     12.5 Latin America Tumor Ablation Market Forecast, by Country
           12.5.1 Brazil Tumor Ablation Market Overview
           12.5.2 Mexico Tumor Ablation Market Overview
           12.5.3 Rest of LATAM Tumor Ablation Market Overview
     12.6 Latin America Market Attractiveness Analysis
     12.7 Market Trends

13 Middle East and Africa Tumor Ablation Market Analysis and Forecast by Region
     13.1 Key Findings
     13.2 Middle East and Africa Tumor Ablation Market Forecast, by Technology
     13.3 Middle East and Africa Tumor Ablation Market Forecast, by Disease Indication
     13.4 Middle East and Africa Tumor Ablation Market Forecast, by End User
     13.5 Middle East and Africa Tumor Ablation Market Forecast, by Country
           13.5.1 South Africa Tumor Ablation Market Overview
           13.5.2 GCC countries Tumor Ablation Market Overview
           13.5.3 Rest of MEA Tumor Ablation Market Overview
     13.6 Middle East and Africa Market Attractiveness Analysis
     13.7 Market Trends

14. Competitive Landscape
     14.1 Market Share Analysis, by Company
     14.2 Competition Matrix
     14.3 Company Profiles
           14.3.1 Medtronic plc.
                    14.3.1.1 Company Details
                    14.3.1.2 Business Overview
                    14.3.1.3 Financial Overview
                    14.3.1.4 Strategic Overview
                    14.3.1.5 SWOT Analysis
           14.3.2 Integra LifeSciences Holdings Corporation
                    14.3.2.1 Company Details
                    14.3.2.2 Business Overview
                    14.3.2.3 Financial Overview
                    14.3.2.4 Strategic Overview
                    14.3.2.5 SWOT Analysis
           14.3.3 BTG International Ltd
                    14.3.3.1 Company Details
                    14.3.3.2 Business Overview
                    14.3.3.3 Financial Overview
                    14.3.3.4 Strategic Overview
                    14.3.3.5 SWOT Analysis
           14.3.4 Boston Scientific Corporation
                    14.3.4.1 Company Details
                    14.3.4.2 Business Overview
                    14.3.4.3 Financial Overview
                    14.3.4.4 Strategic Overview
                    14.3.4.5 SWOT Analysis
           14.3.5 AngioDynamics, Inc.
                    14.3.5.1 Company Details
                    14.3.5.2 Business Overview
                    14.3.5.3 Financial Overview
                    14.3.5.4 Strategic Overview
                    14.3.5.5 SWOT Analysis
           14.3.6 SonaCare Medical, LLC.
                    14.3.6.1 Company Details
                    14.3.6.2 Business Overview
                    14.3.6.3 Financial Overview
                    14.3.6.4 Strategic Overview
                    14.3.6.5 SWOT Analysis
           14.3.7 BVM Medical Limited
                    14.3.7.1 Company Details
                    14.3.7.2 Business Overview
                    14.3.7.3 Financial Overview
                    14.3.7.4 Strategic Overview
                    14.3.7.5 SWOT Analysis
           14.3.8 St. Jude Medical, Inc.
                    14.3.8.1 Company Details
                    14.3.8.2 Business Overview
                    14.3.8.3 Financial Overview
                    14.3.8.4 Strategic Overview
                    14.3.8.5 SWOT Analysis
           14.3.9 EDAP TMS S.A.
                    14.3.9.1 Company Details
                    14.3.9.2 Business Overview
                    14.3.9.3 Financial Overview
                    14.3.9.4 Strategic Overview
                    14.3.9.5 SWOT Analysis

List of Figures

Figure 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 02: Global Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 03: Global Tumor Ablation Technology Market Revenue
Figure 04: Global Tumor Ablation Technology Market Revenue
Figure 05: Global Tumor Ablation Technology Market Revenue
Figure 06: Global Tumor Ablation Technology Market Revenue
Figure 07: Global Tumor Ablation Technology Market Revenue
Figure 08: Global Tumor Ablation Technology Market Revenue
Figure 09: Tumor Ablation Technology Market Attractiveness Analysis by Technology
Figure 10: Global Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 11: Global Tumor Ablation Disease Indication Market Revenue
Figure 12: Global Tumor Ablation Disease Indication Market Revenue
Figure 13: Global Tumor Ablation Disease Indication Market Revenue
Figure 14: Global Tumor Ablation Disease Indication Market Revenue
Figure 15: Global Tumor Ablation Disease Indication Market Revenue
Figure 16: Global Tumor Ablation Disease Indication Market Revenue
Figure 17: Global Tumor Ablation Disease Indication Market Revenue
Figure 18: Tumor Ablation Market Attractiveness Analysis by Disease Indication
Figure 19: Global Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 20: Global Home User Tumor Ablation Market Revenue
Figure 21: Global Clinics Tumor Ablation Market Revenue
Figure 22: Global Hospitals Tumor Ablation Market Revenue
Figure 23: Tumor Ablation Market Attractiveness Analysis by End User
Figure 24: Global Tumor Ablation Market Value Share Analysis by Region Type, 2016 and 2024
Figure 25: Tumor Ablation Market Attractiveness Analysis, By Region Type
Figure 26: North America Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 27: North America Market Attractiveness Analysis by Country
Figure 28: North America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 29: North America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 30: North America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 31: North America Market Value Share Analysis by Country, 2016 and 2024
Figure 32: North America Market Attractiveness Analysis, By Disease Indication
Figure 33: North America Market Attractiveness Analysis, By Technology
Figure 34: North America Market Attractiveness Analysis, By End User
Figure 35: Europe Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 36: Europe Market Attractiveness Analysis by Country
Figure 37: Europe Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 38: Europe Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 39: Europe Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 40: Europe Market Value Share Analysis by Country, 2016 and 2024
Figure 41: Europe Market Attractiveness Analysis, By Disease Indication
Figure 42: Europe Market Attractiveness Analysis, By Technology
Figure 43: Europe Market Attractiveness Analysis, By End User
Figure 44: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 45: Asia Pacific Market Attractiveness Analysis by Country
Figure 46: Asia Pacific Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 47: Asia Pacific Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 48: Asia Pacific Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 49: Asia Pacific Market Value Share Analysis by Country, 2016 and 2024
Figure 50: Asia Pacific Market Attractiveness Analysis, By Disease Indication
Figure 51: Asia Pacific Market Attractiveness Analysis, By Technology
Figure 52: Asia Pacific Market Attractiveness Analysis, By End User
Figure 53: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 54: Latin America Market Attractiveness Analysis by Country
Figure 55: Latin America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 56: Latin America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 57: Latin America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 58: Latin America Market Value Share Analysis by Country, 2016 and 2024
Figure 59: Latin America Market Attractiveness Analysis, By Disease Indication
Figure 60: Latin America Market Attractiveness Analysis, By Technology
Figure 61: Latin America Market Attractiveness Analysis, By End User
Figure 62: MEA Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 63: MEA Market Attractiveness Analysis by Country
Figure 64: MEA Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 65: MEA Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 66: MEA Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 67: MEA Market Value Share Analysis by Country, 2016 and 2024
Figure 68: MEA Market Attractiveness Analysis, By Disease Indication
Figure 69: MEA Market Attractiveness Analysis, By Technology
Figure 70: MEA Market Attractiveness Analysis, By End User
Figure 71: Global Tumor Ablation Market Share Analysis by Company (2015)

List of Table

Table 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 02: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 03: Global Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 04: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Region Type, 2015–2024
Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 06: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 07: North America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 10: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 11: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 12: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 14: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 15: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 16: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 20: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 21: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 22: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 23: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 24: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024

Global Tumor Ablation Market: Overview

Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For tumor ablation procedure Ultrasound (US) or Magnetic Resonance Imaging (MRI), Computed Tomography (CT), is used to guide and position the needle probe into the tumor. A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the tumor ablation market, has been provided in this report. Market revenue for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc.

This report provides in-depth analysis of the tumor ablation market. The stakeholders for this report include companies involved in the manufacturing of ablation devices and its spares parts. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the tumor ablation market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.  

Global Tumor Ablation Market: Segmentation

Based on technology, global tumor ablation market is segmented on the basis of technology are radiofrequency ablation, microwave ablation, Cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others. Based on disease indication, the tumor ablation market are segmented into liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, prostate cancer, and others. End users in the tumor ablation market are, hospitals, cancer specialty clinics, and others (long term care center, research, academics, nursing facility, etc.)

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Spain, Italy, Russia, rest of Europe, India, China, Japan, Australia and New Zealand, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC countries, South Africa and Rest of Middle East and Africa.

Companies Mentioned in the Report

The report also comprises list major players in the market, their SWOT analysis, market share of these players in the tumor ablation, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Medtronic plc, Integra LifeSciences Holdings Corporation, BTG International Ltd, Boston Scientific Corporation, AngioDynamics, Inc., SonaCare Medical, LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A.

The global tumor ablation market has been segmented as follows:

By Technology

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • High-Intensity Focused Ultrasound
  • Laser Interstitial Thermal Ablation
  • Others

By Material

  • Liver cancer
  • Lung cancer
  • Kidney cancer
  • Bone cancer
  • Breast cancer
  • Prostate cancer
  • Others

By End Users

  • Hospitals
  • Cancer Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Russia 
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of MEA


 
 
Back To Top